4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001704336-26-000002
Options or other derivatives
- President & CEO acquired 436,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cloonan Michael President & CEO | 2026-01-02 | Grant or award · Non-Qualified Stock Option (right to buy) | +436,100 | 436,100 | D | ||
Loading xslF345X05/edgardoc.xml…